Post by Cytiva

What if the way we think about manufacturing therapies is ready for a fundamental shift?​ The idea of the body as a bioreactor challenges traditional models, moving from complex external production to enabling therapies to be created where they’re ultimately needed: inside the patient.​ From advances in in vivo therapeutics to the tools accelerating genomic medicine, this shift is opening up entirely new possibilities for how diseases could be treated.​ Explore the thinking behind this approach in our latest whitepaper:​ https://okt.to/r6i309